Alpha Tau Medical (DRTS) Retained Earnings (2020 - 2026)
Alpha Tau Medical (DRTS) posted quarterly Retained Earnings of -$213.1 million for Q1 2026, down 36.41% year-on-year from -$335.1 million in Q1 2025, and down 12.06% on a QoQ basis from -$190.1 million in Q4 2025.
Alpha Tau Medical (DRTS) Retained Earnings (2020 - 2026) Analysis & Trends
Alpha Tau Medical (DRTS) has reported Retained Earnings for 7 consecutive years, with -$213.1 million the latest figure, recorded in Q1 2026.
- Quarterly Retained Earnings fell 36.41% year-over-year to -$213.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$213.1 million (down 36.41% YoY) and the FY2025 annual result came in at -$190.1 million, down 28.9% from the prior year.
- Retained Earnings slipped to -$213.1 million in Q1 2026 per DRTS's latest filing, from -$190.1 million in the prior quarter.
- Over the last five years, Retained Earnings for DRTS reached as high as -$78.6 million in Q1 2022 and fell as low as -$213.1 million in Q1 2026.
- A 5-year average of -$129.1 million and a median of -$123.7 million in 2024 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2022 — Retained Earnings sank 63.89% — and 2023, when it dropped 20.62%.
- Year by year, Retained Earnings stood at -$86.6 million in 2022, then plunged by 33.67% to -$115.8 million in 2023, then dropped by 27.43% to -$147.5 million in 2024, then fell by 28.9% to -$190.1 million in 2025, then decreased by 12.06% to -$213.1 million in 2026.
- According to Business Quant data, Retained Earnings over the past three periods registered -$213.1 million, -$190.1 million, and -$178.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Alpha Tau Medical | 1.19 Bn | 1.11 Bn | - | -213.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -213.08 Mn |
| Dec 31, 2025 | -190.14 Mn |
| Sep 30, 2025 | -178.00 Mn |
| Jun 30, 2025 | -166.31 Mn |
| Mar 31, 2025 | -156.20 Mn |
| Dec 31, 2024 | -147.51 Mn |
| Sep 30, 2024 | -138.03 Mn |
| Jun 30, 2024 | -131.11 Mn |
| Mar 31, 2024 | -123.74 Mn |
| Dec 31, 2023 | -115.76 Mn |
| Sep 30, 2023 | -108.39 Mn |
| Jun 30, 2023 | -103.48 Mn |
| Mar 31, 2023 | -94.79 Mn |
| Dec 31, 2022 | -86.60 Mn |
| Sep 30, 2022 | -83.21 Mn |
| Jun 30, 2022 | -80.58 Mn |
| Mar 31, 2022 | -78.58 Mn |
| Dec 31, 2021 | -52.84 Mn |
| Dec 31, 2020 | -25.57 Mn |